CUL4B and lung carcinoma: The results indicated that, in addition to pancreatic cancer, SIRT1 and CUL4B are also significantly upregulated in esophagus, stomach, rectum, liver, and lung carcinomas, compared with adjacent normal tissues (Fig. 7D).